216 related articles for article (PubMed ID: 11814730)
1. Pediatric tumefactive demyelination: case series and review of the literature.
McAdam LC; Blaser SI; Banwell BL
Pediatr Neurol; 2002 Jan; 26(1):18-25. PubMed ID: 11814730
[TBL] [Abstract][Full Text] [Related]
2. Solitary tumefactive demyelinating lesions in children.
Morin MP; Patenaude Y; Sinsky AB; Banwell B; Sébire G
J Child Neurol; 2011 Aug; 26(8):995-9. PubMed ID: 21555780
[TBL] [Abstract][Full Text] [Related]
3. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children.
Yiu EM; Laughlin S; Verhey LH; Banwell BL;
J Child Neurol; 2014 May; 29(5):654-65. PubMed ID: 24092896
[TBL] [Abstract][Full Text] [Related]
4. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
5. A case of pediatric tumefactive demyelinating lesion misdiagnosed and treated as glioblastoma.
Riva D; Chiapparini L; Pollo B; Balestrini MR; Massimino M; Milani N
J Child Neurol; 2008 Aug; 23(8):944-7. PubMed ID: 18344459
[TBL] [Abstract][Full Text] [Related]
6. Tumefactive demyelinating lesions.
Dagher AP; Smirniotopoulos J
Neuroradiology; 1996 Aug; 38(6):560-5. PubMed ID: 8880719
[TBL] [Abstract][Full Text] [Related]
7. Monophasic, solitary tumefactive demyelinating lesion: neuroimaging features and neuropathological diagnosis.
Tan HM; Chan LL; Chuah KL; Goh NS; Tang KK
Br J Radiol; 2004 Feb; 77(914):153-6. PubMed ID: 15010391
[TBL] [Abstract][Full Text] [Related]
8. Tumefactive Demyelinating Lesions in Children: A Rare Case of Conus Medullaris Involvement and Systematic Review of the Literature.
Pérez CA; Patnaik A; Oommen S; Redko A; Mathis SB
J Child Neurol; 2020 Sep; 35(10):690-699. PubMed ID: 32552343
[TBL] [Abstract][Full Text] [Related]
9. Biopsy-Supported Tumefactive Demyelination of the Central Nervous System in Children.
Hanumanthe SB; Francisco C; Hart J; Graves J; Waubant E
J Child Neurol; 2016 Dec; 31(14):1528-1533. PubMed ID: 27572815
[TBL] [Abstract][Full Text] [Related]
10. Tumefactive demyelination.
Nadkar MY; Deore RA; Singh R
J Assoc Physicians India; 2008 Nov; 56():901-3. PubMed ID: 19263691
[TBL] [Abstract][Full Text] [Related]
11. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
[TBL] [Abstract][Full Text] [Related]
12. Tumefactive demyelinating lesions: nine cases and a review of the literature.
Xia L; Lin S; Wang ZC; Li SW; Xu L; Wu J; Hao SY; Gao CC
Neurosurg Rev; 2009 Apr; 32(2):171-9; discussion 179. PubMed ID: 19172322
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic tumefactive demyelination with underlying combined germ cell cancer.
Broadfoot JR; Archer HA; Coulthard E; Appelman AP; Sutak J; Braybrooke JP; Love S
Pract Neurol; 2015 Dec; 15(6):451-5. PubMed ID: 26088612
[TBL] [Abstract][Full Text] [Related]
14. Perfusion Imaging of Tumefactive Demyelinating Lesions Compared to High Grade Gliomas.
Parks NE; Bhan V; Shankar JJ
Can J Neurol Sci; 2016 Mar; 43(2):316-8. PubMed ID: 26573406
[No Abstract] [Full Text] [Related]
15. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy and diffusion-weighted imaging of tumefactive demyelinating plaque.
Masu K; Beppu T; Fujiwara S; Kizawa H; Kashimura H; Kurose A; Ogasawara K; Sasaki M
Neurol Med Chir (Tokyo); 2009 Sep; 49(9):430-3. PubMed ID: 19779292
[TBL] [Abstract][Full Text] [Related]
17. Tumefactive demyelinating lesions of 15 patients: Clinico-radiological features, management and review of the literature.
Sánchez P; Meca-Lallana V; Barbosa A; Manzanares R; Palmí I; Vivancos J
J Neurol Sci; 2017 Oct; 381():32-38. PubMed ID: 28991707
[TBL] [Abstract][Full Text] [Related]
18. Contralateral recurrence of tumefactive demyelination.
Khan MN; Guranda M; Essig M
Neuroradiol J; 2015 Oct; 28(5):493-7. PubMed ID: 26427896
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma.
Thebault S; Hanes I; Woulfe J; Bourque PR
Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e527. PubMed ID: 30588483
[No Abstract] [Full Text] [Related]
20. Neutropenia as a Complication of Tumefactive Demyelinating Disease: A Case Report.
Webb K; Osorio M
PM R; 2018 Aug; 10(8):877-879. PubMed ID: 29330070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]